基本信息
　　姓名: 张东伟
　　Email: zhdw1006@163.com
工作经历
　　2012.06—至今 　　　北京中医药大学基础医学院　　副教授
　　2010.06—2012.08　　加拿大不列颠哥伦比亚大学　　博士后、副研究员
　　2006.10—2010.05　　加拿大不列颠哥伦比亚大学　　博士后
　　2004.07—2006.10　　清华大学化学系　　　　　　　博士后
教育经历
　　2001.9—2004.7　北京中医药大学，博士 (生物化学)
　　1998.9—2001.7　河南中医学院，硕士（中药药理学）
　　1993.9—1997.7　河南中医学院，学士（中药学）
教学经历
　　《高级分子生物学实验》、《生物化学》、《中药学》
研究方向
　　[1].代谢性疾病的发病机理和天然药物的防治；
　　[2].天然产物中小分子的抑制剂研发；.
　　[3].蛋白酶和疾病的关系；
　　[4].药物作用的生化机理和创新药物的研发.
科学研究
　　[1].2019年国家自然基金青年基金项目：基于Sema3A/Nrp1/PlexinA1信号通路探讨女贞子抗骨质疏松的分子机制和物质基础（**），56万元，2019/01-2022/12；
　　[2].2017年北京市自然基金面上项目：基于Wnt/β-Catenin研究女贞子对去卵巢骨质疏松大鼠的作用机理和物质基础（**）, 2017/01-2019/12, 20万；
　　[3].以菊芋为主的健康产品和食品的市场开发（横向课题），2016/12/10-2018/12/10，30万；
　　[4].八子补肾方抗衰老的作用机理研究（横向课题），2016/9/30-2018/12/31，68.5万；
　　[5].2013年国家自然基金面上项目：基于中药选择性Cathepsin K活性的抑制剂对骨质疏松分子作用机理的研究（**），2013/01-2016/12, 70万；
学术兼职
　　[1]中国老年学和老年医学学会骨质疏松分会（OSCG）骨内科专业委员会、中医药分会常务委员（2017—至今）；
　　[2]世界中医药学会联合会糖尿病专业委员会理事（2017—至今）；
　　[3]《中国骨质疏松杂志》常委编委（2015—至今）；
　　[4]《医学参考报?骨质疏松频道》青年编委会副主任会员。
发表主要文章 SCI收录(*责任作者)
　　[1].Liu C+, Wang L+, Zhu R+, Liu H+, Ma R, Chen B, Li L, Guo Y, Jia Q, Shi S, Zhao D, Mo F, Zhao B, Niu J, Fu M, Orekhov AN, Br?mme D, Gao S, Zhang D*. Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/β-catenin signaling pathway in OVX rats. Osteoporos Int. 2018 Aug 27. doi: 10.1007/s00198-018-4670-y. IF=3. 856
　　[2].Panwar P, Law S, Jamroz, Azizi P, Zhang D, Ciufolini M, Br?mme D*. Tanshinones that selectively block the collagenase activity of cathepsin K provide a novel class of ectosteric antiresorptive agents for bone. Br J Pharmacol. 2018;175(6):902-923. IF= 5.491.
　　[3].Beibei Chen+, Lili Wang+, Lin Li+, Ruyuan Zhu , Haixia Liu, Chenyue Liu, Rufeng Ma, Qiangqiang Jia, Dandan Zhao, Jianzhao Niu, Min Fu, Sihua Gao, Dongwei Zhang*. Fructus Ligustri Lucidi in Osteoporosis: A Review of its Pharmacology, Phytochemistry, Pharmacokinetics and Safety. Molecules, 2017, 22(9), 1469. IF=3.098
　　[4].Zhu R, Liu H, Liu C, Wang L, Ma R, Chen B, Li L, Niu J, Fu M, Zhang D*, Gao S*. Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety. Pharmacological Research. 2017, 122:78-89. IF=4.897
　　[5].Wang L, Ma R, Guo Y, Sun J, Liu H, Zhu R, Liu C, Li J, Li L, Chen B, Sun L, Tang J, Zhao D, Mo F, Niu J, Jiang G, Fu M, Br?mme D, Zhang D*, Gao S. Antioxidant Effect of Fructus Ligustri Lucidi Aqueous Extract in Ovariectomized Rats Is Mediated through Nox4-ROS-NF-κB Pathway. Frontiers in Pharmacology. 2017,8:266. IF=3.831
　　[6].Wang L, Ma R, Liu C, Liu H, Zhu R, Guo S, Tang M, Li Y, Niu J, Fu M, Gao S*, Zhang D*. Salvia miltiorrhiza: A potential red light to the development of cardiovascular diseases. Current Pharmaceutical Design. 2017, 23(7):1077-1097. IF=2.757
　　[7].Ma R, Wang L, Zhao B, Liu C, Liu H, Zhu R, Chen B, Li L, Zhao D, Mo F, Li Y, Niu J, Jiang G, Fu M, Bromme D, Gao S*, Zhang D*. Diabetes Perturbs Bone Microarchitecture and Bone Strength through Regulation of Sema3A/IGF-1/β-Catenin in Rats. Celluar Physiology and Biochemistry. 2017;41(1):55-66. IF=5.5
　　[8].Haixia Liu, Ruyuan Zhu, Chenyue Liu, Rufeng Ma, Lili Wang, Beibei Chen, Lin Li, Jianzhao Niu, Dandan Zhao, Fangfang Mo, Min Fu, Dieter Bromme, Dongwei Zhang*, and Sihua Gao*. Evaluation of Decalcification Techniques for Rat Femurs Using HE and Immunohistochemical Staining. BioMed Research International. 2017; 2017: **. IF=2.583
　　[9].Attané C, Peyot ML, Lussier R, Poursharifi P, Zhao S, Zhang D, Morin J, Pineda M, Wang S, Dumortier O, Ruderman NB, Mitchell GA, Simons B, Madiraju SR, Joly E, Prentki M*. A beta cell ATGL-lipolysis/adipose tissue axis controls energy homeostasis and body weight via insulin secretion in mice. Diabetologia. 2016, 59(12):2654-2663. IF=6.206
　　[10].Mugabo Y, Zhao S, Seifried A, Gezzar S, Al-Mass A, Zhang D, Lamontagne J, Attane C, Poursharifi P, Iglesias J, Joly E, Peyot ML, Gohla A, Madiraju SR, Prentki M. Identification of a mammalian glycerol-3-phosphate phosphatase: Role in metabolic control and signaling in pancreatic β–cells and hepatocytes. Proceedings of the National Academy of Sciences. 2016;113(4):E430-9. IF=9.423
　　[11].Rufeng Ma, Ruyuan Zhu, Lili Wang, Yubo Guo, Chenyue Liu, Haixia Liu, Fengwei Liu, Hongjun Li, Yu Li, Min Fu, Dongwei Zhang*. Diabetic osteoporosis: A review of its traditional Chinese medicinal use, clinical and preclinical research. Evid Based Complement Alternat Med. 2016; 2016:**. IF=1.74
　　[12].Yubo Guo, Lili Wang, Rufeng Ma, Qianqian Mu, Na Yu, Yi Zhang, Yuqing Tang, Yu Li, Guangjian Jiang, Dandan Zhao, Fangfang Mo, Sihua Gao*, Meijuan Yang, Feifei Kan, Qun Ma, Min Fu, Dongwei Zhang*. JiangTang XiaoKe granule attenuates cathepsin K expression and improves IGF-1 expression in the bone of high fat diet induced KK-Ay diabetic mice. Life Sciences. 2016, 148: 24-30. IF=2.936
　　[13].Lili Wang, Yu Li, Yubo Guo, Rufeng Ma, Min Fu, Jianzhao Niu, Sihua Gao, Dongwei Zhang*. Herba Epimedii: An ancient Chinese herbal medicine in the prevention and treatment of osteoporosis. Current Pharmaceutical Design. 2016, 22(3):328-49. IF=2.861
　　[14].Fu XY, Zhang DW#, Li YD, Zhao PW, Tang YQ, Niu JZ, Li Y*. Curcumin Treatment Suppresses CCR7 Expression and the Differentiation and Migration of Human Circulating Fibrocytes. Cell Physiol Biochem. 2015;35(2):489-98. IF=4.652
　　[15].Yubo Guo, Yu Li, Liming Xue, Richele P. Severino, Sihua Gao, Jianzhao Niu, Lu-Ping Qin, Dongwei Zhang*, Dieter Br?mme*. Salvia miltiorrhiza: An ancient Chinese herbal medicine as a source for anti-osteoporotic drugs. J Ethnopharmacol. 2014, 155(3):1401-16. IF=2.998
　　[16].Dong-wei Zhang*, Min Fu, Si-Hua Gao, and Jun-Li Liu. Curcumin and Diabetes: A Systematic Review. Evidence-Based Complementary and Alternative Medicine, 2013, 2013：636053. IF=1.77
　　（更新时间：2018年10月）